Europe DTC Laboratory Testing Market (2025-2032)
The Europe DTC Laboratory Testing Market is projected to reach $1.59 billion by 2032, at a CAGR of 10.8% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 160
- Format
- PDF + Excel
- Report ID
- MRHC - 104958
- Base year
- 2024
- 2032 · FORECAST
- $1.59B
- 2032
- $1.59B
- CAGR 2025–2032
- 10.8%
2024 baseline · 2025–2032 forecast at 10.8% CAGR · hover a bar for the value
Key highlights
The Europe DTC Laboratory Testing Market is projected to reach $1.59 billion by 2032, at a CAGR of 10.8% from 2025 to 2032.
The genetic testing segment is expected to account for the largest share of the market.
The blood segment is expected to account for the largest share of the market.
The growth of the Europe direct-to-consumer laboratory testing market is driven by several factors, including the rising incidence of chronic diseases & sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 1.59 billion |
| CAGR (2025–2032) | 10.8% |
| Format | PDF, Excel & Cloud Portal · 160 pages |
| Segments Covered | By Application: Genetic Testing Ancestry/Genealogy, Disease Risk Assessment Cancer, Cardiovascular Diseases, Neurological Diseases, Other Diseases · By Sample Type: Blood, Saliva, Urine, Other Samples |
| Countries Covered | Europe (RoE) |
| Key Companies | LetsGetChecked, Inc., Cerascreen Biotech LLC, Living DNA Ltd, SelfDiagnostics Deutschland GmbH, SYNLAB International GmbH, Mainz Biomed Germany GmbH |
Report overview
Segments covered: application, sample type. Regions: Europe.
Direct-to-consumer, DTC tests, or at-home genetic tests, are medical or genetic tests that consumers can order and perform at home without the involvement of a healthcare professional. These tests have become increasingly popular in recent years due to advancements in genetic testing technology and increased consumer interest in understanding their genetic makeup. The sample collected from the consumer is processed at a laboratory, and the results are sent directly to the consumer.
The growth of the Europe direct-to-consumer laboratory testing market is driven by several factors, including the rising incidence of chronic diseases & sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Factors such as the growing adoption of telehealth, expansion in emerging economies, and increasing penetration of pharmacogenomic testing in DTC laboratory testing are some opportunities that would help grow the market. Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counseling could be challenges for the Europe direct-to-consumer laboratory testing market. However, sample integrity and interference issues, regulatory concerns, lack of reimbursement, and the limited test portfolio compared to conventional laboratory testing restrain the market's growth.
Report infographic
Market dynamics
1 factors across 1 forceRising Prevalence of Chronic, Infectious, & Sexually Transmitted Diseases
The rising prevalence of chronic & infectious diseases is expected to drive the demand for DTC laboratory testing. Many DTC laboratory testing companies are offering tests for diagnosing infectious diseases and monitoring chronic diseases. In the case of sexually transmitted diseases (STDs), there has been a stigma surrounding it, leading to people not approaching healthcare providers for STD testing. Direct-to-consumer laboratory testing solves this problem by offering discretion and confidentiality to consumers. According to the European Centre for Disease Prevention and Control (ECDC), it is estimated that every year, over 500,000 sexually transmitted infections (STIs) are notified in the U.K. Thus, the advantages of DTC lab testing, such as discretion & confidentiality and the increased prevalence of sexually transmitted diseases, are expected to drive the demand for DTC lab testing.
Table of contents
10 chapters · 91 sections · 160 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By All the Application | Genetic Testing | — |
| By Sample Type | Blood | — |
By All the Application
- The genetic testing segment is expected to account for the largest share of the market.
- DTC genetic tests are those that are provided directly to consumers without involving a healthcare provider.
- This testing generally offers a wide range of genetic tests that can be helpful to provide consumers with information about their ancestry, health risks, and traits.
- This segment is driven by factors such as increasing awareness regarding personal health management, high curiosity about self-ancestry, strong marketing strategies by the companies, rising prevalence of various genetic & chronic diseases, and high demand for personalized testing services.
By Sample Type
- The blood segment is expected to account for the largest share of the market.
- The blood sample is collected from consumers to test conditions such as diabetes, routine clinical testing, thyroid function, and sexually transmitted disease testing, among others, in order to gain insight into how the organs are functioning.
- Blood samples are collected using a lancet or a needle that is present in the kit provided to carry out the test.
- This segment is driven by factors such as a large variety of available tests using blood samples.
- Increasing prevalence of various chronic diseases and increasing consumer awareness regarding the monitoring of chronic diseases.
Geographic analysis
Europe
The growth of the Europe direct-to-consumer laboratory testing market is driven by several factors, including the rising incidence of chronic diseases & sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Competitive landscape
- LetsGetChecked, Inc.
- Cerascreen Biotech LLC
- Living DNA Ltd
- SelfDiagnostics Deutschland GmbH
- SYNLAB International GmbH
- Mainz Biomed Germany GmbH
Frequently asked questions
This market study covers the market sizes & forecasts of the direct-to-consumer (DTC) laboratory testing market in Europe based on application, sample type, and geography. This market study also provides the value analysis of various segments and subsegments of the Europe direct-to-consumer laboratory testing market at country levels.
Cite this report
Meticulous Research. (2025). Europe DTC Laboratory Testing Market - Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104958). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/europe-dtc-laboratory-testing-market-5641